In a twist, a grassroots letter writing campaign has produced thousands of comments from individuals to the Centers for Medicare and Medicaid Services arguing against Medicare coverage for Alzheimer’s drugs like Biogen, Inc. and Eisai Co., Ltd.’s Aduhelm.
Organized by national community activist organization More Perfect Union, the campaign has resulted in approximately 4,700 submissions to CMS regarding...